TMX1 and neoplasm: Collectively, our results appear that TMX family genes may participate in modulating tumor cell sensitivity or resistance to drug treatment, and therefore hold promise as potential therapeutic targets for overcoming drug-induced resistance or enhancing drug sensitivity as a complement to existing therapies.